The prevalence of and risk factors for androgen deficiency in aging Taiwanese men.

INTRODUCTION Androgen deficiency in aging men has attracted much medical interest. Most studies on androgen deficiency have been conducted in Caucasian populations, and data from other ethnicities are lacking. AIM To evaluate the prevalence of and risk factors for androgen deficiency and symptomatic androgen deficiency in Taiwanese men over 40 years old. METHODS From August 2007 to April 2008, a free health screening was conducted by a medical center in Kaohsiung, Taiwan, and 819 men participated in this health screening. All participants completed a health questionnaire, received a detailed physical examination, and blood samples were drawn between 8:00 and 12:00 am. MAIN OUTCOME MEASURES Serum total testosterone (TT), albumin, and sex hormone-binding globulin levels were measured. The level of free testosterone (FT) was calculated. Clinical symptoms of androgen deficiency were assessed using the Androgen Deficiency in the Aging Male (ADAM) questionnaire. RESULTS Seven hundred thirty-four men who met the inclusion criteria (mean age 57.4 +/- 6.7 years; range: 43-87 years) were included in this study. The prevalence of androgen deficiency was 24.1% based on the criterion of TT level < 300 ng/dL, and 16.6% based on the criterion of both TT < 300 ng/dL and FT < 5 ng/dL. The prevalence of symptomatic androgen deficiency was 12.0%. Both prevalence of androgen deficiency and symptomatic androgen deficiency increased with age. Older age, obesity, and diabetes mellitus were independent risk factors for androgen deficiency and symptomatic androgen deficiency. CONCLUSIONS In a sample of aging Taiwanese men, a substantial proportion had androgen deficiency and symptomatic androgen deficiency, and the prevalence increased with age. Older age, obesity, and diabetes mellitus were independent risk factors for androgen deficiency and symptomatic androgen deficiency. Those potentially modifiable risk factors like obesity and diabetes mellitus should be prevented to maintain normal testosterone levels during aging in men.

[1]  G. Balercia,et al.  Low levels of androgens in men with erectile dysfunction and obesity. , 2008, The journal of sexual medicine.

[2]  J. S. St. Sauver,et al.  The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men. , 2008, The journal of sexual medicine.

[3]  A. Silman,et al.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. , 2008, The Journal of clinical endocrinology and metabolism.

[4]  T. Travison,et al.  The Natural History of Symptomatic Androgen Deficiency in Men: Onset, Progression, and Spontaneous Remission , 2008, Journal of the American Geriatrics Society.

[5]  M. Monga,et al.  Prevalence of androgen deficiency in men with erectile dysfunction. , 2008, Urology.

[6]  Merlin C. Thomas,et al.  Low testosterone levels are common and associated with insulin resistance in men with diabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  K-C Huang,et al.  Obesity and its related diseases in Taiwan , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[8]  T. Hwang,et al.  The relationship between hypogonadism and erectile dysfunction , 2008, International Journal of Impotence Research.

[9]  M. Dowsett,et al.  Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.

[10]  Hang Lee,et al.  Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  T. Travison,et al.  Prevalence of symptomatic androgen deficiency in men. , 2007, The Journal of clinical endocrinology and metabolism.

[12]  G. Dangas,et al.  Cardiovascular morbidity and mortality of the metabolic syndrome. , 2007, The Medical clinics of North America.

[13]  T. Jones,et al.  Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome , 2007 .

[14]  Wen-Jeng Wu,et al.  Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. , 2007, Urology.

[15]  R. Quinton,et al.  The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. , 2007, The journal of sexual medicine.

[16]  G. Balercia,et al.  ORIGINAL RESEARCH—ENDOCRINOLOGY: NCEP‐ATPIII‐Defined Metabolic Syndrome, Type 2 Diabetes Mellitus, and Prevalence of Hypogonadism in Male Patients with Sexual Dysfunction , 2007 .

[17]  A. Araujo,et al.  Sex steroids and all-cause and cause-specific mortality in men. , 2007, Archives of internal medicine.

[18]  A. C. Tsai,et al.  Interview to study the determinants of hypertension in older adults in Taiwan: a population based cross-sectional survey. , 2007, Asia Pacific journal of clinical nutrition.

[19]  W. Sheu,et al.  Serum testosterone level and related metabolic factors in men over 70 years old , 2007, Journal of endocrinological investigation.

[20]  W. Zohdy,et al.  Androgen deficiency and abnormal penile duplex parameters in obese men with erectile dysfunction. , 2007, The journal of sexual medicine.

[21]  Jang-Ming Lee,et al.  Anatomical subsite discrepancy in relation to the impact of the consumption of alcohol, tobacco and betel quid on esophageal cancer , 2007, International journal of cancer.

[22]  J. Svartberg Epidemiology: testosterone and the metabolic syndrome , 2007, International Journal of Impotence Research.

[23]  H. Raff,et al.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. , 2007, The Journal of clinical endocrinology and metabolism.

[24]  T. Travison,et al.  The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. , 2007, The Journal of clinical endocrinology and metabolism.

[25]  E. Nieschlag,et al.  Association of specific symptoms and metabolic risks with serum testosterone in older men. , 2006, The Journal of clinical endocrinology and metabolism.

[26]  J. Tostain,et al.  Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology. , 2006, European urology.

[27]  H. Chiang,et al.  Correlations of androgen deficiency with clinical symptoms in Taiwanese males , 2006, International Journal of Impotence Research.

[28]  A. Stemhagen,et al.  Prevalence of hypogonadism in males aged at least 45 years: the HIM study , 2006, International journal of clinical practice.

[29]  K. Channer,et al.  Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. , 2006, European journal of endocrinology.

[30]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[31]  D. Nathan,et al.  Insulin sensitivity during combined androgen blockade for prostate cancer. , 2006, The Journal of clinical endocrinology and metabolism.

[32]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[33]  T. Travison,et al.  Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. , 2006, The Journal of clinical endocrinology and metabolism.

[34]  A. Traish,et al.  ORIGINAL RESEARCH—ENDOCRINOLOGY: The Physiological Role of Androgens in Penile Erection: Regulation of Corpus Cavernosum Structure and Function , 2005 .

[35]  A. Lenzi,et al.  Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis , 2005, Clinical endocrinology.

[36]  Yoav Ben-Shlomo,et al.  Cortisol, Testosterone, and Coronary Heart Disease: Prospective Evidence From the Caerphilly Study , 2005, Circulation.

[37]  J. Kaufman,et al.  EAU GuidelinesInvestigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations , 2005 .

[38]  J. Kaufman,et al.  Investigation, treatment and monitoring of late-onset hypogonadism in males , 2005, The aging male : the official journal of the International Society for the Study of the Aging Male.

[39]  Tomi-Pekka Tuomainen,et al.  The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. , 2005, The Journal of clinical endocrinology and metabolism.

[40]  A. Araujo,et al.  Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. , 2004, The Journal of clinical endocrinology and metabolism.

[41]  A. Seftel Androgens Regulate Phosphodiesterase Type 5 Expression and Functional Activity in Corpora Cavernosa , 2004 .

[42]  G. Reaven The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. , 2004, Endocrinology and metabolism clinics of North America.

[43]  L. Niskanen,et al.  Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. , 2004, Diabetes care.

[44]  M. Tschöp,et al.  Testosterone replacement therapy restores normal ghrelin in hypogonadal men. , 2003, The Journal of clinical endocrinology and metabolism.

[45]  A. von Eckardstein,et al.  Androgens and coronary artery disease. , 2003, Endocrine reviews.

[46]  W. Pan,et al.  Prevalence and awareness of diabetes and mean fasting glucose by age, sex, and region: results from the Nutrition and Health Survey in Taiwan, 1993–1996 , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[47]  A. Araujo,et al.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. , 2002, The Journal of clinical endocrinology and metabolism.

[48]  B. Balkau,et al.  Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. , 2001, Diabetes care.

[49]  H. Bujo,et al.  [Obesity and its related diseases]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[50]  E. Metter,et al.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. , 2001, The Journal of clinical endocrinology and metabolism.

[51]  H. Perry,et al.  Validation of a screening questionnaire for androgen deficiency in aging males. , 2000, Metabolism: clinical and experimental.

[52]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[53]  P. Fisher,et al.  INSULIN SENSITIVITY , 1940, Northwest medicine.

[54]  J. Kaufman,et al.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. , 2009, European urology.

[55]  E. Barrett-Connor,et al.  Low serum testosterone and mortality in older men. , 2008, The Journal of clinical endocrinology and metabolism.

[56]  L. Kennedy Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly Men , 2008 .

[57]  H. Chiou,et al.  Association among hypogonadism, quality of life and erectile dysfunction in middle-aged and aged male in Taiwan , 2007, International Journal of Impotence Research.

[58]  A. Meikle Testosterone and Estradiol among Older Men , 2007 .

[59]  Testosterone replacement therapy for male aging: ASA position statement. , 2006, Journal of andrology.

[60]  A. Isidori,et al.  Androgens, cardiovascular disease and osteoporosis. , 2005, Journal of endocrinological investigation.

[61]  Wen-Harn Pan,et al.  Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. , 2004, The American journal of clinical nutrition.

[62]  G. B. Phillips Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. , 1993, Metabolism: clinical and experimental.